Krystal Biotech Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Krystal Biotech Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KRYS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001711279
Board of directors
-
Catherine Mazzacco · DirectorSince 2023
-
Christopher Mason · DirectorSince 2023
-
Daniel Janney · DirectorSince 2023
-
Dino A. Rossi · DirectorSince 2023
-
Everett Rand Sutherland · DirectorSince 2023
-
Julian S. Gangolli · DirectorSince 2023
-
Krish S. Krishnan · Director · President and CEOSince 2023
-
Suma Krishnan · Director · President, R&DSince 2023
Chief executives
Krish S. Krishnan
· President and CEO
Dates unknown
Board connections
3 of this board's directors also sit on 3 other boards.
- via Julian S. Gangolli
- via Catherine Mazzacco
- via Everett Rand Sutherland
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −1,639 | $175.97 | $288,415 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −1,100 | $175.83 | $193,413 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −4,579 | $176.88 | $809,934 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −4,944 | $176.80 | $874,099 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −10,937 | $177.66 | $1,943,067 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −10,931 | $177.62 | $1,941,564 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −6,514 | $178.76 | $1,164,443 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −6,769 | $178.77 | $1,210,094 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −1,331 | $179.55 | $238,981 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −1,256 | $179.57 | $225,540 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −1,100 | $175.83 | $193,413 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −1,639 | $175.97 | $288,415 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −4,944 | $176.80 | $874,099 |
| Mar 13, 2025 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −4,579 | $176.88 | $809,934 |
| Mar 13, 2025 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −10,931 | $177.62 | $1,941,564 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.